TY - JOUR
T1 - Specific and Label-Free bioFET Sensing of the Interaction Between the Electrically Neutral Small Estriol Molecule and Its Antibody in a Microliter Drop of Diluted Plasma
AU - Babbar, Shubham
AU - Garika, Vijay
AU - Samanta, Soumadri
AU - Bhattarai, Shankar
AU - Sadhujan, Sumesh
AU - Harilal, Sherina
AU - Pikhay, Evgeny
AU - Shima-Edelstein, Ruth
AU - Greental, Doron
AU - Eisenberg-Lerner, Avital
AU - Rotfogel, Ziv
AU - Bashouti, Muhammad Y.
AU - Akabayov, Barak
AU - Ron, Izhar
AU - Roizin, Yakov
AU - Erez, Offer
AU - Shalev, Gil
N1 - Publisher Copyright:
© 2024 The Authors. Advanced Electronic Materials published by Wiley-VCH GmbH.
PY - 2024/6/1
Y1 - 2024/6/1
N2 - The sensing of small molecules is important to a variety of fields and particularly to clinical diagnostics. Estriol is an important small chemical molecule, as it is one of three markers measured during mid-gestation for the Down syndrome. Point-of-care testing of estriol will increase maternal compliance for aneuploidy mid-gestation screening. A bioFET technology is a promising point-of-care platform. The meta-nano-channel (MNC) bioFET is employed with its tunable channel configuration to optimize the coupling between the electrostatics of the estriol-receptor interactions and the electrodynamics of the conducting readout current. Also, the MNC bioFET receptor layer is composed of anti-estriol antibodies to address the high structural similarity of estriol to other estrogens. Despite the small size and the electrical neutrality of estriol, real-time is demonstrated, specific, and label-free sensing of estriol in 0.5 µL of 1:100 diluted plasma with excellent linearity, sensitivity, dynamic range extending to ten orders of magnitude in estriol concentration and limit-of-detection of 1 fg mL−1. Extensive control and non-specific measurements are reported including the response to other neutral members of the estrogen family.
AB - The sensing of small molecules is important to a variety of fields and particularly to clinical diagnostics. Estriol is an important small chemical molecule, as it is one of three markers measured during mid-gestation for the Down syndrome. Point-of-care testing of estriol will increase maternal compliance for aneuploidy mid-gestation screening. A bioFET technology is a promising point-of-care platform. The meta-nano-channel (MNC) bioFET is employed with its tunable channel configuration to optimize the coupling between the electrostatics of the estriol-receptor interactions and the electrodynamics of the conducting readout current. Also, the MNC bioFET receptor layer is composed of anti-estriol antibodies to address the high structural similarity of estriol to other estrogens. Despite the small size and the electrical neutrality of estriol, real-time is demonstrated, specific, and label-free sensing of estriol in 0.5 µL of 1:100 diluted plasma with excellent linearity, sensitivity, dynamic range extending to ten orders of magnitude in estriol concentration and limit-of-detection of 1 fg mL−1. Extensive control and non-specific measurements are reported including the response to other neutral members of the estrogen family.
KW - antibody-small molecule interactions
KW - bioFET
KW - biosensing
KW - estriol
KW - field-effect sensing
UR - http://www.scopus.com/inward/record.url?scp=85190889250&partnerID=8YFLogxK
U2 - 10.1002/aelm.202300819
DO - 10.1002/aelm.202300819
M3 - Article
AN - SCOPUS:85190889250
SN - 2199-160X
VL - 10
JO - Advanced Electronic Materials
JF - Advanced Electronic Materials
IS - 6
M1 - 2300819
ER -